Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Jirwe (2011)
Analysing qualitative data.Nurse researcher, 18 3
C. Pope, S. Ziebland, N. Mays (2000)
QUALITATIVE RESEARCH IN HEALTH CARE: ANALYZING QUALITATIVE DATA, 320
(2016)
Policy for maintenance pharmacotherapy for opioid dependence
B. Larance, L. Degenhardt, Susannah O'Brien, N. Lintzeris, A. Winstock, R. Mattick, J. Bell, R. Ali (2011)
Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.Drug and alcohol review, 30 6
E. Digiusto, A. Shakeshaft, A. Ritter, R. Mattick, J. White, N. Lintzeris, J. Bell, J. Saunders (2006)
Effects of Pharmacotherapies for Opioid Dependence on Participants' Criminal Behaviour and Expenditure on Illicit Drugs: An Australian National Evaluation (NEPOD)Australian & New Zealand Journal of Criminology, 39
A. Winstock, Toby Lea, J. Sheridan (2008)
Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.Drug and alcohol review, 27 4
(2017)
Standard 2: partnering with consumers. Canberra, National Safety and Quality Standards
S. Darke, J. Ross, W. Hall (1996)
Overdose among heroin users in Sydney, Australia: II. responses to overdose.Addiction, 91 3
J. Chalmers, A. Ritter (2012)
Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system.Drug and alcohol review, 31 7
Phuong-Phi Le, E. Hotham (2008)
South Australian rural community pharmacists and the provision of methadone, buprenorphine and injecting equipmentInternational Journal of Pharmacy Practice, 16
R. Chisin (2009)
Cost-Effectiveness AnalysisJournal of Nuclear Medicine, 50
N. Gisev, M. Shanahan, D. Weatherburn, R. Mattick, S. Larney, L. Burns, L. Degenhardt (2015)
A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.Addiction, 110 12
J. Ross, M. Teesson, S. Darke, M. Lynskey, R. Ali, A. Ritter, R. Cooke (2005)
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).Drug and alcohol review, 24 5
T. Moore, A. Ritter, J. Caulkins (2007)
The costs and consequences of three policy options for reducing heroin dependency.Drug and alcohol review, 26 4
L. Burns, D. Randall, W. Hall, M. Law, T. Butler, J. Bell, L. Degenhardt (2009)
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.Addiction, 104 8
J. Ward, W. Hall, R. Mattick (1999)
Role of maintenance treatment in opioid dependenceThe Lancet, 353
C. Treloar, J. Rance, A. Madden, L. Liebelt (2011)
Evaluation of Consumer Participation Demonstration Projects in Five Australian Drug User Treatment Facilities: The Impact of Individual Versus Organizational Stability in Determining Project ProgressSubstance Use & Misuse, 46
L. Degenhardt, D. Randall, W. Hall, M. Law, T. Butler, L. Burns (2009)
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.Drug and alcohol dependence, 105 1-2
(2015)
National opioid pharmacotherapy statistics 2014
Toby Lea, J. Sheridan, A. Winstock (2008)
Consumer satisfaction with opioid treatment services at community pharmacies in AustraliaPharmacy World & Science, 30
Rafina Khateeb, T. Gandhi, G. Dhaliwal (2013)
A raw deal.Journal of hospital medicine, 8 8
(2010)
Victorian pharmacotherapy review. Sydney: National Drug and Alcohol Research Centre
(2009)
Modelling pharmacotherapy maintenance
S. Holliday, P. Magin, C. Oldmeadow, J. Attia, J. Dunbabin, Julie-Marie Henry, N. Lintzeris, Susan Goode, A. Dunlop (2013)
An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy.Drug and alcohol review, 32 5
S. Fraser (2006)
The chronotope of the queue: Methadone maintenance treatment and the production of time, space and subjectsInternational Journal of Drug Policy, 17
L. Degenhardt, S. Larney, J. Kimber, N. Gisev, M. Farrell, T. Dobbins, D. Weatherburn, A. Gibson, R. Mattick, T. Butler, L. Burns (2014)
The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.Addiction, 109 8
T King, A Ritter, L Berends (2010)
Victorian pharmacotherapy review
C. Longman, M. Temple-Smith, G. Gilchrist, N. Lintzeris (2012)
Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy.Australian journal of primary health, 18 4
P. Cronin, F. Ryan, M. Coughlan (2008)
Undertaking a literature review: a step-by-step approach.British journal of nursing, 17 1
L. Burns, N. Gisev, S. Larney, T. Dobbins, A. Gibson, J. Kimber, B. Larance, R. Mattick, T. Butler, L. Degenhardt (2015)
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.Addiction, 110 4
C. Treloar, S. Fraser, Kylie Valentine (2007)
Valuing methadone takeaway doses: The contribution of service-user perspectives to policy and practiceDrugs: Education, Prevention and Policy, 14
Sione Crawford (2013)
Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.The International journal on drug policy, 24 6
C. Doran, M. Shanahan, E. Digiusto, Susannah O'Brien, R. Mattick (2006)
Cost-effectiveness analysis of maintenance agonist treatments in the NEPODExpert Review of Pharmacoeconomics & Outcomes Research, 6
G. Peterson, M. Wu, J. Bergin (1999)
Pharmacists’ attitudes towards dispensing errors: their causes and preventionJournal of Clinical Pharmacy and Therapeutics, 24
A. Winstock, Toby Lea, J. Sheridan (2010)
Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.Addiction, 105 2
(2005)
Opioid substitution therapy considering the costs
D. Horyniak, P. Dietze, B. Larance, A. Winstock, L. Degenhardt (2011)
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.The International journal on drug policy, 22 2
L. Amato, M. Davoli, C. Perucci, M. Ferri, F. Faggiano, R. Mattick (2005)
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.Journal of substance abuse treatment, 28 4
Jeff Hall (1997)
Methadone Maintenance Treatment and other Opioid Replacement Therapies
G. Fitzsimmons, K. Sadkowsky (2014)
From the Australian Institute of Health and WelfareMedical Journal of Australia, 200
P Muhleisen, N Clark, A Teo, D Brogan (2005)
Opioid substitution therapy considering the costs to consumersOf Substance: The National Magazine on Alcohol, Tobacco and Other Drugs, 3
Peter Lawrinson, A. Roche, Hiroe Terao, Phuong-Phi Le (2008)
Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.Drug and alcohol review, 27 1
(2004)
National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations
(2009)
Polygon: the many sides to the Australian opioid pharmacotherapy
A. Shepherd, Bianca Perrella, H. Hattingh (2014)
The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods studySubstance Abuse Treatment, Prevention, and Policy, 9
J. Koplan, H Director, Robert Milstein, S. Wetterhall, H Chair, G. Christenson, Dennis-Flagler, Jeffrey Harris, L. Donna, Higgins, A. Kenneth, M. Schachter, Nancy Pegg, Janet Collins, Diane Dunet, Aliki Pappas, Alison Kelly, P. Placek, Michael Hennessy, D. Rugg, April Bell, A. Deborah, M. Deppe, I. Martin, Meltzer, D. Sarah, H Wiley, Thomas Bartenfeld, R. Bernier, M. Lum, G. Cole, K. Cahill, Carmack, E. Nancy, Cheal, Hope King, M. Anthony, D. Moulton, E. Rosner, W. Kassler, J. Neal, L. Doll, C. Gollmar, R. Goodman, Wilma Johnson, M. Pappaioanou, D. Sencer, D. Snider, M. Speers, L. Tylor, Kelly 'brien, M. Yehl, D. Washington, P. Mccumiskey, T. Tinker, Jeanne Alongi, P. Briss, A. Dannenberg, D. Fishbein, Dennis Jarvis, Mark Messonnier, B. Myers, R. Romaguera, S. Thacker, B. Truman, K. Turner, J. Wiley, G. Williamson, S. Zaza, Cynthia Jorgensen, M. Kreuter, R. Lancaster, M. 'at, Ed M, Elizabeth Majestic, D. Mcqueen, Diane Narkunas, D. Niemeyer, L. Ravello, Jami Fraze, Joan Morrissey, W. Parra, J. Qualters, Michael Sage, Joseph Smith, Ronald Stoddard, M. Greenberg, Jennfier Madans, Huey-tsyh Chen, Janet Cleveland, H. Dixon, Janice Hiland, Richard Jenkins, Jill Leslie, M. Lobato, K. MacQueen, N. Qualls, C. Branche, L. Dahlberg, D. Sleet, S. Chu, L. Rodewald, L. Goldenhar, Travis Kubale, P. Drehobl, M. Hatcher, L. Cheryl, Scott, Catherine Shoemaker, Brian Siegmund, P. Sinnock, Suzanne Adair, M. Avery, Atlanta, Georgia, R. Bialek, M. Washington, L. Bickman, T. Chapel, D. Compton, R. Conner, D. Cotton, Bruce Davidson, Controllers Association, Pennsylvania Philadelphia, Mary Davis, W. Dyal, S. Fawcett, N. Freudenberg, J. Gearing, Kristine Gebbe, Rebecca Kudon, Lynne Greabell, Susan Griffin, Texas Austin, S. Hammond, A. Haddix, S. Hassig, Gary Henry, J. Hersey, Carolina Park, Rich Hoffman, Epidemiologists, Colorado Denver, R. Hornik, Eric Juzenas, A. Public, Health Association, Mark Keegan, Health Officers, Jeffrey Koshel, Services, Amy Lewis, Human Services, Raleigh, Carolina, Jennifer Lewis, D. Loe, A. Marsh, Mental Health, Service Administration, P. Mathison, D. Mcbride, Washington, K. Miner, April Montgomery, Genevieve Nagy, Dennis Murphy, M. Butler, Virginia, Carol Pitts, H. Preskill, C. Roddy, Duane Ken, M. Runkle, J. Sanders, M. University, MI Kalamazoo, L. Scarpetta, Mark Schrader, G. Human, R. Department, Leonard Schwartz, Harvey Schwartz, William Smith, Edith Sternberg, Susan Toal, J. Olphen, P. Wiesner, R. Yin (1999)
Framework for program evaluation in public health.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 48 RR-11
To review the literature regarding the value and consumer focus of research on opioid replacement therapy (ORT) programs, relevant to the Australian rural context and community pharmacy. We conducted a narrative review of literature published between 1995 and 2015, searching EBSCOhost, PubMed and Google Scholar. Three authors collaborated to screen and synthesise studies. Effectiveness, cost affordability, diversion and retention benefits were reported from pharmacological or prescribers’ or dispensers’ standpoint. Research was fragmented and evaluated contributions of these individual types of stakeholders with less discussion of consumers, or consumers’ everyday experiences of ORT. No studies took into account consumers’ psychosocial aspects or power discourses. We found ORT as a beneficial treatment for opioid dependence is well researched, although overall Australian program evaluation was lacking. A gap within ORT literature should be addressed by making consumer experiences central in designs for future research and for program evaluation.
International Journal of Mental Health and Addiction – Springer Journals
Published: Feb 5, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.